Document 0044
 DOCN  M9550044
 TI    [Gene therapy and ethics]
 DT    9505
 AU    Muller H; Rehmann-Sutter C; Abteilung Medizinische Genetik,
       Universitatskinderklinik, Basel.
 SO    Schweiz Med Wochenschr. 1995 Jan 10;125(1-2):34-41. Unique Identifier :
       AIDSLINE MED/95141036
 AB    Gene therapy represents a new strategy to treat human disorders. It was
       originally conceived as a cure for severe monogenetic disorders. Since
       its conception, the spectrum of possible application for gene therapy
       has been to include the treatment of acquired diseases, such as various
       forms of cancer and some viral infections, most notably human immune
       deficiency virus (HIV) and hepatitis B virus. Since somatic gene therapy
       does not cause substantially new ethical problems, it has gained broad
       approval. This is by no means the case with germ-line gene therapy.
       Practically all bodies who were evaluating the related ethical aspects
       wanted to ban its medical application on grounds of fundamental and
       pragmatic considerations. In this review, practical and ethical views
       concerning gene therapy are summarized which were presented at the
       Junitagung 1994 of the Swiss Society for Biomedical Ethics in Basle.
 DE    English Abstract  *Ethics, Medical  *Gene Therapy  Genetic Engineering
       Germ-Line Mutation  Human  Reproduction Techniques  JOURNAL ARTICLE
       REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).